Company page

Biomarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc. is a publicly traded company listed under the ticker BMRN on the American stock market. With a market capitalization of approximately $10.57 billion, Biomarin focuses on developing innovative biopharmaceuticals for serious diseases and medical conditions. The company is committed to advancing therapies that address unmet medical needs.